This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

GLORIA-AF Registry Program - Second and Third Phases

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Boehringer Ingelheim
ClinicalTrials.gov Identifier:
NCT01468701
First received: October 28, 2011
Last updated: August 25, 2017
Last verified: August 2017
  Purpose
In this part of the Registry Program patients with non-valvular atrial fibrillation (AF) at risk for stroke are enrolled to characterize the target population and to collect real world data on important outcome events. For administrative purposes the study is divided into two protocol numbers: 1160.129 for all non-EU (European Union) and non-EEA (European Economic Area) countries, and 1160.136 for EU and EEA countries. The total number of patients enrolled in both protocols is estimated to be 48,000 patients, and all these patients will be included in the data analysis for study 1160.129.

Condition
Stroke Atrial Fibrillation

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)

Resource links provided by NLM:


Further study details as provided by Boehringer Ingelheim:

Primary Outcome Measures:
  • Myocardial infarction [ Time Frame: up to 3 years ]
  • Life-threatening bleeding events [ Time Frame: up to 3 years ]
  • All cause death [ Time Frame: up to 3 years ]
  • Vascular death [ Time Frame: up to 3 years ]
  • composite endpoint: Stroke, systemic embolism, myocardial infarction and vascular death (vascular composite endpoint) [ Time Frame: up to 3 years ]
  • Stroke (hemorrhagic and ischemic, uncertain classification) [ Time Frame: up to 3 years ]
  • Transient Ischemic attack (TIA) [ Time Frame: up to 3 years ]
  • Systemic embolism [ Time Frame: up to 3 years ]
  • Pulmonary embolism [ Time Frame: up to 3 years ]
  • composite endpoint: stroke, systemic embolism, myocardial infarction, life-threatening bleeding events and vascular death [ Time Frame: up to 3 years ]
  • Major bleeding events (including life-threatening bleeding events) [ Time Frame: up to 3 years ]

Estimated Enrollment: 19000
Actual Study Start Date: November 7, 2011
Estimated Study Completion Date: January 14, 2020
Estimated Primary Completion Date: January 14, 2020 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with non-valvular AF
Criteria

Inclusion criteria:

  1. Age =>18 years at enrollment
  2. Male or female patient (or legally acceptable representative) willing and able to provide written informed consent
  3. Patient newly diagnosed (< 3 months prior to baseline visit) with non-valvular AF and at risk for stroke.

Other inclusion criteria apply.

Exclusion criteria:

  1. Presence of any mechanical heart valve, or valve disease that is expected to require valve replacement intervention;
  2. Patients who have received more than 60 days of vitamin K antagonist (VKA) treatment in their lifetime;
  3. AF with a generally reversible cause;
  4. Patients with a medical condition other than atrial fibrillation for which chronic use of an oral anticoagulant (for example, a VKA) is indicated Other exclusion criteria apply
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01468701

  Hide Study Locations
Locations
United States, Alabama
1160.129.32394 Boehringer Ingelheim Investigational Site
Mobile, Alabama, United States
1160.129.32174 Boehringer Ingelheim Investigational Site
Northport, Alabama, United States
1160.129.32054 Boehringer Ingelheim Investigational Site
Scottsboro, Alabama, United States
United States, Alaska
1160.129.32335 Boehringer Ingelheim Investigational Site
Anchorage, Alaska, United States
United States, Arizona
1160.129.32284 Boehringer Ingelheim Investigational Site
Glendale, Arizona, United States
1160.129.32156 Boehringer Ingelheim Investigational Site
Hot Springs, Arizona, United States
1160.129.32151 Boehringer Ingelheim Investigational Site
Lake Havasu City, Arizona, United States
United States, Arkansas
1160.129.32266 Boehringer Ingelheim Investigational Site
Fort Smith, Arkansas, United States
1160.129.32140 Boehringer Ingelheim Investigational Site
Hot Springs, Arkansas, United States
1160.129.32009 Boehringer Ingelheim Investigational Site
Little Rock, Arkansas, United States
1160.129.32014 Boehringer Ingelheim Investigational Site
Little Rock, Arkansas, United States
1160.129.32356 Boehringer Ingelheim Investigational Site
Little Rock, Arkansas, United States
United States, California
1160.129.32035 Boehringer Ingelheim Investigational Site
Encinitas, California, United States
1160.129.32126 Boehringer Ingelheim Investigational Site
Fountain Valley, California, United States
1160.129.32019 Boehringer Ingelheim Investigational Site
Fresno, California, United States
1160.129.32305 Boehringer Ingelheim Investigational Site
Hawaiian Gardens, California, United States
1160.129.32225 Boehringer Ingelheim Investigational Site
La Jolla, California, United States
1160.129.32216 Boehringer Ingelheim Investigational Site
La Mesa, California, United States
1160.129.32039 Boehringer Ingelheim Investigational Site
Los Alamitos, California, United States
1160.129.32426 Boehringer Ingelheim Investigational Site
Los Angeles, California, United States
1160.129.32326 Boehringer Ingelheim Investigational Site
Northridge, California, United States
1160.129.32329 Boehringer Ingelheim Investigational Site
Palo Alto, California, United States
1160.129.32170 Boehringer Ingelheim Investigational Site
Rancho Mirage, California, United States
1160.129.32017 Boehringer Ingelheim Investigational Site
San Diego, California, United States
1160.129.32370 Boehringer Ingelheim Investigational Site
Santa Ana, California, United States
1160.129.32102 Boehringer Ingelheim Investigational Site
Stockton, California, United States
1160.129.32167 Boehringer Ingelheim Investigational Site
Temecula, California, United States
1160.129.32381 Boehringer Ingelheim Investigational Site
Torrance, California, United States
1160.129.32196 Boehringer Ingelheim Investigational Site
Ventura, California, United States
1160.129.32205 Boehringer Ingelheim Investigational Site
Ventura, California, United States
1160.129.32249 Boehringer Ingelheim Investigational Site
Ventura, California, United States
1160.129.32104 Boehringer Ingelheim Investigational Site
Visalia, California, United States
United States, Colorado
1160.129.32031 Boehringer Ingelheim Investigational Site
Aurora, Colorado, United States
1160.129.32021 Boehringer Ingelheim Investigational Site
Colorado Springs, Colorado, United States
1160.129.32204 Boehringer Ingelheim Investigational Site
Colorado Springs, Colorado, United States
1160.129.32393 Boehringer Ingelheim Investigational Site
Denver, Colorado, United States
1160.129.32317 Boehringer Ingelheim Investigational Site
Littleton, Colorado, United States
United States, Connecticut
1160.129.32193 Boehringer Ingelheim Investigational Site
Bridgeport, Connecticut, United States
1160.129.32233 Boehringer Ingelheim Investigational Site
Bridgeport, Connecticut, United States
1160.129.32268 Boehringer Ingelheim Investigational Site
Bridgeport, Connecticut, United States
1160.129.32074 Boehringer Ingelheim Investigational Site
Norwalk, Connecticut, United States
1160.129.32303 Boehringer Ingelheim Investigational Site
Norwalk, Connecticut, United States
1160.129.32152 Boehringer Ingelheim Investigational Site
Shelton, Connecticut, United States
United States, Delaware
1160.129.32066 Boehringer Ingelheim Investigational Site
Newark, Delaware, United States
United States, District of Columbia
1160.129.32202 Boehringer Ingelheim Investigational Site
Washington, D.C., District of Columbia, United States
1160.129.32314 Boehringer Ingelheim Investigational Site
Washington, D.C., District of Columbia, United States
1160.129.32414 Boehringer Ingelheim Investigational Site
Washington, D.C., District of Columbia, United States
United States, Florida
1160.129.32270 Boehringer Ingelheim Investigational Site
Aventura, Florida, United States
1160.129.32144 Boehringer Ingelheim Investigational Site
Brandon, Florida, United States
1160.129.32119 Boehringer Ingelheim Investigational Site
Clearwater, Florida, United States
1160.129.32048 Boehringer Ingelheim Investigational Site
Delray Beach, Florida, United States
1160.129.32291 Boehringer Ingelheim Investigational Site
Doral, Florida, United States
1160.129.32132 Boehringer Ingelheim Investigational Site
Gainesville, Florida, United States
1160.129.32347 Boehringer Ingelheim Investigational Site
Hialeah, Florida, United States
1160.129.32128 Boehringer Ingelheim Investigational Site
Hollywood, Florida, United States
1160.129.32427 Boehringer Ingelheim Investigational Site
Jacksonville, Florida, United States
1160.129.32090 Boehringer Ingelheim Investigational Site
Jupiter, Florida, United States
1160.129.32079 Boehringer Ingelheim Investigational Site
Lakeland, Florida, United States
1160.129.32018 Boehringer Ingelheim Investigational Site
Miami, Florida, United States
1160.129.32124 Boehringer Ingelheim Investigational Site
Miami, Florida, United States
1160.129.32212 Boehringer Ingelheim Investigational Site
Miami, Florida, United States
1160.129.32222 Boehringer Ingelheim Investigational Site
Miami, Florida, United States
1160.129.32309 Boehringer Ingelheim Investigational Site
Miami, Florida, United States
1160.129.32312 Boehringer Ingelheim Investigational Site
Miami, Florida, United States
1160.129.32125 Boehringer Ingelheim Investigational Site
Miramar Beach, Florida, United States
1160.129.32383 Boehringer Ingelheim Investigational Site
Naples, Florida, United States
1160.129.32005 Boehringer Ingelheim Investigational Site
New Smyrna Beach, Florida, United States
1160.129.32147 Boehringer Ingelheim Investigational Site
Oakland Park, Florida, United States
1160.129.32182 Boehringer Ingelheim Investigational Site
Orlando, Florida, United States
1160.129.32318 Boehringer Ingelheim Investigational Site
Pembroke Pines, Florida, United States
1160.129.32239 Boehringer Ingelheim Investigational Site
Pensacola, Florida, United States
1160.129.32208 Boehringer Ingelheim Investigational Site
Port Charlotte, Florida, United States
1160.129.32259 Boehringer Ingelheim Investigational Site
Rockledge, Florida, United States
1160.129.32057 Boehringer Ingelheim Investigational Site
Saint Petersburg, Florida, United States
1160.129.32116 Boehringer Ingelheim Investigational Site
Saint Petersburg, Florida, United States
1160.129.32402 Boehringer Ingelheim Investigational Site
Saint Petersburg, Florida, United States
1160.129.32006 Boehringer Ingelheim Investigational Site
Sarasota, Florida, United States
1160.129.32248 Boehringer Ingelheim Investigational Site
Sarasota, Florida, United States
1160.129.32313 Boehringer Ingelheim Investigational Site
Sarasota, Florida, United States
1160.129.32020 Boehringer Ingelheim Investigational Site
Seminole, Florida, United States
1160.129.32064 Boehringer Ingelheim Investigational Site
Tallahassee, Florida, United States
1160.129.32277 Boehringer Ingelheim Investigational Site
Tampa, Florida, United States
1160.129.32342 Boehringer Ingelheim Investigational Site
Vero Beach, Florida, United States
1160.129.32037 Boehringer Ingelheim Investigational Site
Wellington, Florida, United States
United States, Georgia
1160.129.32253 Boehringer Ingelheim Investigational Site
Atlanta, Georgia, United States
1160.129.32302 Boehringer Ingelheim Investigational Site
Atlanta, Georgia, United States
1160.129.32435 Boehringer Ingelheim Investigational Site
Atlanta, Georgia, United States
1160.129.32185 Boehringer Ingelheim Investigational Site
Cumming, Georgia, United States
1160.129.32083 Boehringer Ingelheim Investigational Site
Decatur, Georgia, United States
1160.129.32401 Boehringer Ingelheim Investigational Site
Macon, Georgia, United States
United States, Idaho
1160.129.32096 Boehringer Ingelheim Investigational Site
Coeur d'Alene, Idaho, United States
United States, Illinois
1160.129.32283 Boehringer Ingelheim Investigational Site
Arlington Heights, Illinois, United States
1160.129.32071 Boehringer Ingelheim Investigational Site
Belleville, Illinois, United States
1160.129.32375 Boehringer Ingelheim Investigational Site
Carbondale, Illinois, United States
1160.129.32044 Boehringer Ingelheim Investigational Site
Chicago, Illinois, United States
1160.129.32065 Boehringer Ingelheim Investigational Site
Chicago, Illinois, United States
1160.129.32103 Boehringer Ingelheim Investigational Site
Chicago, Illinois, United States
1160.129.32293 Boehringer Ingelheim Investigational Site
Chicago, Illinois, United States
1160.129.32298 Boehringer Ingelheim Investigational Site
Chicago, Illinois, United States
1160.129.32354 Boehringer Ingelheim Investigational Site
Chicago, Illinois, United States
1160.129.32412 Boehringer Ingelheim Investigational Site
Chicago, Illinois, United States
1160.129.32117 Boehringer Ingelheim Investigational Site
Hinsdale, Illinois, United States
1160.129.32003 Boehringer Ingelheim Investigational Site
Melrose Park, Illinois, United States
1160.129.32133 Boehringer Ingelheim Investigational Site
Morton, Illinois, United States
1160.129.32275 Boehringer Ingelheim Investigational Site
Rock Island, Illinois, United States
1160.129.32391 Boehringer Ingelheim Investigational Site
Winfield, Illinois, United States
United States, Indiana
1160.129.32001 Boehringer Ingelheim Investigational Site
Brownsburg, Indiana, United States
1160.129.32376 Boehringer Ingelheim Investigational Site
Fort Wayne, Indiana, United States
1160.129.32245 Boehringer Ingelheim Investigational Site
Indianapolis, Indiana, United States
1160.129.32320 Boehringer Ingelheim Investigational Site
LaPorte, Indiana, United States
1160.129.32046 Boehringer Ingelheim Investigational Site
Munster, Indiana, United States
1160.129.32327 Boehringer Ingelheim Investigational Site
South Bend, Indiana, United States
United States, Iowa
1160.129.32042 Boehringer Ingelheim Investigational Site
Ames, Iowa, United States
1160.129.32411 Boehringer Ingelheim Investigational Site
Iowa City, Iowa, United States
1160.129.32055 Boehringer Ingelheim Investigational Site
Waterloo, Iowa, United States
1160.129.32089 Boehringer Ingelheim Investigational Site
West Des Moines, Iowa, United States
United States, Kansas
1160.129.32029 Boehringer Ingelheim Investigational Site
Overland Park, Kansas, United States
United States, Kentucky
1160.129.32025 Boehringer Ingelheim Investigational Site
Elizabethtown, Kentucky, United States
1160.129.32392 Boehringer Ingelheim Investigational Site
Louisville, Kentucky, United States
1160.129.32422 Boehringer Ingelheim Investigational Site
Madisonville, Kentucky, United States
1160.129.32188 Boehringer Ingelheim Investigational Site
Mount Sterling, Kentucky, United States
1160.129.32059 Boehringer Ingelheim Investigational Site
Owensboro, Kentucky, United States
1160.129.32431 Boehringer Ingelheim Investigational Site
Owensboro, Kentucky, United States
United States, Louisiana
1160.129.32176 Boehringer Ingelheim Investigational Site
Alexandria, Louisiana, United States
1160.129.32286 Boehringer Ingelheim Investigational Site
Baton Rouge, Louisiana, United States
1160.129.32201 Boehringer Ingelheim Investigational Site
Bossier City, Louisiana, United States
1160.129.32045 Boehringer Ingelheim Investigational Site
Hammond, Louisiana, United States
1160.129.32271 Boehringer Ingelheim Investigational Site
Kenner, Louisiana, United States
1160.129.32235 Boehringer Ingelheim Investigational Site
Lake Charles, Louisiana, United States
1160.129.32274 Boehringer Ingelheim Investigational Site
New Orleans, Louisiana, United States
1160.129.32429 Boehringer Ingelheim Investigational Site
Shreveport, Louisiana, United States
1160.129.32164 Boehringer Ingelheim Investigational Site
Slidell, Louisiana, United States
United States, Maine
1160.129.32122 Boehringer Ingelheim Investigational Site
Biddeford, Maine, United States
United States, Maryland
1160.129.32226 Boehringer Ingelheim Investigational Site
Annapolis, Maryland, United States
1160.129.32228 Boehringer Ingelheim Investigational Site
Baltimore, Maryland, United States
1160.129.32421 Boehringer Ingelheim Investigational Site
Clinton, Maryland, United States
1160.129.32388 Boehringer Ingelheim Investigational Site
Columbia, Maryland, United States
1160.129.32148 Boehringer Ingelheim Investigational Site
Salisbury, Maryland, United States
1160.129.32155 Boehringer Ingelheim Investigational Site
Salisbury, Maryland, United States
1160.129.32229 Boehringer Ingelheim Investigational Site
Towson, Maryland, United States
United States, Massachusetts
1160.129.32203 Boehringer Ingelheim Investigational Site
Ayer, Massachusetts, United States
1160.129.32382 Boehringer Ingelheim Investigational Site
Brighton, Massachusetts, United States
1160.129.32013 Boehringer Ingelheim Investigational Site
Fall River, Massachusetts, United States
1160.129.32289 Boehringer Ingelheim Investigational Site
Newton, Massachusetts, United States
United States, Michigan
1160.129.32036 Boehringer Ingelheim Investigational Site
Alpena, Michigan, United States
1160.129.32234 Boehringer Ingelheim Investigational Site
Bay City, Michigan, United States
1160.129.32135 Boehringer Ingelheim Investigational Site
Detroit, Michigan, United States
1160.129.32340 Boehringer Ingelheim Investigational Site
Erie, Michigan, United States
1160.129.32047 Boehringer Ingelheim Investigational Site
Flint, Michigan, United States
1160.129.32168 Boehringer Ingelheim Investigational Site
Grand Blanc, Michigan, United States
1160.129.32264 Boehringer Ingelheim Investigational Site
Grand Blanc, Michigan, United States
1160.129.32052 Boehringer Ingelheim Investigational Site
Lansing, Michigan, United States
1160.129.32142 Boehringer Ingelheim Investigational Site
Marquette, Michigan, United States
1160.129.32232 Boehringer Ingelheim Investigational Site
Mount Clemens, Michigan, United States
1160.129.32053 Boehringer Ingelheim Investigational Site
Niles, Michigan, United States
1160.129.32282 Boehringer Ingelheim Investigational Site
Novi, Michigan, United States
1160.129.32075 Boehringer Ingelheim Investigational Site
Saginaw, Michigan, United States
1160.129.32231 Boehringer Ingelheim Investigational Site
Saginaw, Michigan, United States
United States, Minnesota
1160.129.32405 Boehringer Ingelheim Investigational Site
Duluth, Minnesota, United States
1160.129.32280 Boehringer Ingelheim Investigational Site
Minneapolis, Minnesota, United States
1160.129.32190 Boehringer Ingelheim Investigational Site
Saint Cloud, Minnesota, United States
1160.129.32307 Boehringer Ingelheim Investigational Site
Saint Paul, Minnesota, United States
United States, Mississippi
1160.129.32339 Boehringer Ingelheim Investigational Site
Biloxi, Mississippi, United States
1160.129.32408 Boehringer Ingelheim Investigational Site
Jackson, Mississippi, United States
United States, Missouri
1160.129.32364 Boehringer Ingelheim Investigational Site
Kansas City, Missouri, United States
1160.129.32404 Boehringer Ingelheim Investigational Site
Saint Joseph, Missouri, United States
1160.129.32101 Boehringer Ingelheim Investigational Site
Saint Louis, Missouri, United States
1160.129.32184 Boehringer Ingelheim Investigational Site
Saint Louis, Missouri, United States
1160.129.32297 Boehringer Ingelheim Investigational Site
Saint Louis, Missouri, United States
United States, Montana
1160.129.32165 Boehringer Ingelheim Investigational Site
Kalispell, Montana, United States
United States, Nebraska
1160.129.32321 Boehringer Ingelheim Investigational Site
Omaha, Nebraska, United States
1160.129.32331 Boehringer Ingelheim Investigational Site
Omaha, Nebraska, United States
1160.129.32396 Boehringer Ingelheim Investigational Site
Omaha, Nebraska, United States
1160.129.32199 Boehringer Ingelheim Investigational Site
Papillion, Nebraska, United States
United States, Nevada
1160.129.32180 Boehringer Ingelheim Investigational Site
Reno, Nevada, United States
1160.129.32407 Boehringer Ingelheim Investigational Site
Reno, Nevada, United States
United States, New Jersey
1160.129.32154 Boehringer Ingelheim Investigational Site
Bridgewater, New Jersey, United States
1160.129.32380 Boehringer Ingelheim Investigational Site
Camden, New Jersey, United States
1160.129.32242 Boehringer Ingelheim Investigational Site
Eatontown, New Jersey, United States
1160.129.32386 Boehringer Ingelheim Investigational Site
Hackensack, New Jersey, United States
1160.129.32179 Boehringer Ingelheim Investigational Site
Haddon Heights, New Jersey, United States
1160.129.32030 Boehringer Ingelheim Investigational Site
Linden, New Jersey, United States
1160.129.32378 Boehringer Ingelheim Investigational Site
Manalapan, New Jersey, United States
1160.129.32049 Boehringer Ingelheim Investigational Site
Neptune City, New Jersey, United States
1160.129.32389 Boehringer Ingelheim Investigational Site
New Brunswick, New Jersey, United States
1160.129.32255 Boehringer Ingelheim Investigational Site
Paterson, New Jersey, United States
1160.129.32221 Boehringer Ingelheim Investigational Site
Ridgewood, New Jersey, United States
1160.129.32099 Boehringer Ingelheim Investigational Site
Somerset, New Jersey, United States
1160.129.32007 Boehringer Ingelheim Investigational Site
South Plainfield, New Jersey, United States
1160.129.32069 Boehringer Ingelheim Investigational Site
Voorhees, New Jersey, United States
1160.129.32198 Boehringer Ingelheim Investigational Site
Voorhees, New Jersey, United States
1160.129.32269 Boehringer Ingelheim Investigational Site
West Orange, New Jersey, United States
United States, New Mexico
1160.129.32311 Boehringer Ingelheim Investigational Site
Albuquerque, New Mexico, United States
United States, New York
1160.129.32332 Boehringer Ingelheim Investigational Site
Albany, New York, United States
1160.129.32246 Boehringer Ingelheim Investigational Site
Brooklyn, New York, United States
1160.129.32015 Boehringer Ingelheim Investigational Site
Camillus, New York, United States
1160.129.32379 Boehringer Ingelheim Investigational Site
Cooperstown, New York, United States
1160.129.32387 Boehringer Ingelheim Investigational Site
Flushing, New York, United States
1160.129.32278 Boehringer Ingelheim Investigational Site
Johnson City, New York, United States
1160.129.32038 Boehringer Ingelheim Investigational Site
Mineola, New York, United States
1160.129.32110 Boehringer Ingelheim Investigational Site
New York, New York, United States
1160.129.32361 Boehringer Ingelheim Investigational Site
New York, New York, United States
1160.129.32372 Boehringer Ingelheim Investigational Site
New York, New York, United States
1160.129.32432 Boehringer Ingelheim Investigational Site
Saratoga Springs, New York, United States
1160.129.32299 Boehringer Ingelheim Investigational Site
Stony Brook, New York, United States
1160.129.32139 Boehringer Ingelheim Investigational Site
Syracuse, New York, United States
1160.129.32397 Boehringer Ingelheim Investigational Site
Syracuse, New York, United States
1160.129.32173 Boehringer Ingelheim Investigational Site
The Bronx, New York, United States
1160.129.32263 Boehringer Ingelheim Investigational Site
Westfield, New York, United States
1160.129.32016 Boehringer Ingelheim Investigational Site
Williamsville, New York, United States
United States, North Carolina
1160.129.32265 Boehringer Ingelheim Investigational Site
Burlington, North Carolina, United States
1160.129.32070 Boehringer Ingelheim Investigational Site
Hickory, North Carolina, United States
1160.129.32033 Boehringer Ingelheim Investigational Site
High Point, North Carolina, United States
1160.129.32114 Boehringer Ingelheim Investigational Site
Jacksonville, North Carolina, United States
1160.129.32251 Boehringer Ingelheim Investigational Site
Kannapolis, North Carolina, United States
1160.129.32072 Boehringer Ingelheim Investigational Site
Lenoir, North Carolina, United States
1160.129.32073 Boehringer Ingelheim Investigational Site
Pinehurst, North Carolina, United States
1160.129.32162 Boehringer Ingelheim Investigational Site
Raleigh, North Carolina, United States
1160.129.32215 Boehringer Ingelheim Investigational Site
Wilson, North Carolina, United States
United States, North Dakota
1160.129.32118 Boehringer Ingelheim Investigational Site
Fargo, North Dakota, United States
1160.129.32220 Boehringer Ingelheim Investigational Site
Minot, North Dakota, United States
United States, Ohio
1160.129.32436 Boehringer Ingelheim Investigational Site
Canton, Ohio, United States
1160.129.32350 Boehringer Ingelheim Investigational Site
Cincinnati, Ohio, United States
1160.129.32273 Boehringer Ingelheim Investigational Site
Cleveland, Ohio, United States
1160.129.32257 Boehringer Ingelheim Investigational Site
Fairfield, Ohio, United States
1160.129.32061 Boehringer Ingelheim Investigational Site
Fairview Park, Ohio, United States
1160.129.32060 Boehringer Ingelheim Investigational Site
Hudson, Ohio, United States
1160.129.32183 Boehringer Ingelheim Investigational Site
Kettering, Ohio, United States
1160.129.32158 Boehringer Ingelheim Investigational Site
Marion, Ohio, United States
1160.129.32316 Boehringer Ingelheim Investigational Site
Marion, Ohio, United States
1160.129.32012 Boehringer Ingelheim Investigational Site
Miamisburg, Ohio, United States
1160.129.32244 Boehringer Ingelheim Investigational Site
Springfield, Ohio, United States
1160.129.32285 Boehringer Ingelheim Investigational Site
Toledo, Ohio, United States
1160.129.32349 Boehringer Ingelheim Investigational Site
Toledo, Ohio, United States
1160.129.32428 Boehringer Ingelheim Investigational Site
Willoughby, Ohio, United States
1160.129.32032 Boehringer Ingelheim Investigational Site
Youngstown, Ohio, United States
United States, Oklahoma
1160.129.32258 Boehringer Ingelheim Investigational Site
Oklahoma City, Oklahoma, United States
1160.129.32425 Boehringer Ingelheim Investigational Site
Oklahoma City, Oklahoma, United States
United States, Oregon
1160.129.32374 Boehringer Ingelheim Investigational Site
Corvallis, Oregon, United States
1160.129.32163 Boehringer Ingelheim Investigational Site
Portland, Oregon, United States
1160.129.32366 Boehringer Ingelheim Investigational Site
Springfield, Oregon, United States
United States, Pennsylvania
1160.129.32400 Boehringer Ingelheim Investigational Site
Abington, Pennsylvania, United States
1160.129.32236 Boehringer Ingelheim Investigational Site
Camp Hill, Pennsylvania, United States
1160.129.32086 Boehringer Ingelheim Investigational Site
Carnegie, Pennsylvania, United States
1160.129.32206 Boehringer Ingelheim Investigational Site
Chambersburg, Pennsylvania, United States
1160.129.32157 Boehringer Ingelheim Investigational Site
Doylestown, Pennsylvania, United States
1160.129.32398 Boehringer Ingelheim Investigational Site
Ephrata, Pennsylvania, United States
1160.129.32113 Boehringer Ingelheim Investigational Site
Harleysville, Pennsylvania, United States
1160.129.32127 Boehringer Ingelheim Investigational Site
Jersey Shore, Pennsylvania, United States
1160.129.32153 Boehringer Ingelheim Investigational Site
Lansdale, Pennsylvania, United States
1160.129.32323 Boehringer Ingelheim Investigational Site
Philadelphia, Pennsylvania, United States
1160.129.32337 Boehringer Ingelheim Investigational Site
Philadelphia, Pennsylvania, United States
1160.129.32371 Boehringer Ingelheim Investigational Site
Philadelphia, Pennsylvania, United States
1160.129.32406 Boehringer Ingelheim Investigational Site
Pittsburgh, Pennsylvania, United States
1160.129.32192 Boehringer Ingelheim Investigational Site
Sellersville, Pennsylvania, United States
1160.129.32109 Boehringer Ingelheim Investigational Site
Warminster, Pennsylvania, United States
1160.129.32137 Boehringer Ingelheim Investigational Site
Yardley, Pennsylvania, United States
United States, Rhode Island
1160.129.32224 Boehringer Ingelheim Investigational Site
Pawtucket, Rhode Island, United States
1160.129.32384 Boehringer Ingelheim Investigational Site
Wakefield, Rhode Island, United States
United States, South Carolina
1160.129.32160 Boehringer Ingelheim Investigational Site
Anderson, South Carolina, United States
1160.129.32243 Boehringer Ingelheim Investigational Site
Anderson, South Carolina, United States
1160.129.32002 Boehringer Ingelheim Investigational Site
Beaufort, South Carolina, United States
1160.129.32050 Boehringer Ingelheim Investigational Site
Columbia, South Carolina, United States
1160.129.32424 Boehringer Ingelheim Investigational Site
Greenwood, South Carolina, United States
1160.129.32108 Boehringer Ingelheim Investigational Site
Myrtle Beach, South Carolina, United States
United States, South Dakota
1160.129.32267 Boehringer Ingelheim Investigational Site
Rapid City, South Dakota, United States
United States, Tennessee
1160.129.32217 Boehringer Ingelheim Investigational Site
Chattanooga, Tennessee, United States
1160.129.32338 Boehringer Ingelheim Investigational Site
Jackson, Tennessee, United States
1160.129.32272 Boehringer Ingelheim Investigational Site
Johnson City, Tennessee, United States
1160.129.32080 Boehringer Ingelheim Investigational Site
Knoxville, Tennessee, United States
1160.129.32082 Boehringer Ingelheim Investigational Site
Knoxville, Tennessee, United States
1160.129.32287 Boehringer Ingelheim Investigational Site
Knoxville, Tennessee, United States
United States, Texas
1160.129.32145 Boehringer Ingelheim Investigational Site
Austin, Texas, United States
1160.129.32095 Boehringer Ingelheim Investigational Site
Beaumont, Texas, United States
1160.129.32252 Boehringer Ingelheim Investigational Site
Dallas, Texas, United States
1160.129.32290 Boehringer Ingelheim Investigational Site
Dallas, Texas, United States
1160.129.32322 Boehringer Ingelheim Investigational Site
Dallas, Texas, United States
1160.129.32300 Boehringer Ingelheim Investigational Site
Fort Worth, Texas, United States
1160.129.32105 Boehringer Ingelheim Investigational Site
Grapevine, Texas, United States
1160.129.32092 Boehringer Ingelheim Investigational Site
Houston, Texas, United States
1160.129.32100 Boehringer Ingelheim Investigational Site
Houston, Texas, United States
1160.129.32123 Boehringer Ingelheim Investigational Site
Houston, Texas, United States
1160.129.32295 Boehringer Ingelheim Investigational Site
Houston, Texas, United States
1160.129.32301 Boehringer Ingelheim Investigational Site
Houston, Texas, United States
1160.129.32219 Boehringer Ingelheim Investigational Site
Humble, Texas, United States
1160.129.32171 Boehringer Ingelheim Investigational Site
Katy, Texas, United States
1160.129.32211 Boehringer Ingelheim Investigational Site
Kingwood, Texas, United States
1160.129.32260 Boehringer Ingelheim Investigational Site
Lubbock, Texas, United States
1160.129.32189 Boehringer Ingelheim Investigational Site
New Braunfels, Texas, United States
1160.129.32187 Boehringer Ingelheim Investigational Site
San Antonio, Texas, United States
1160.129.32238 Boehringer Ingelheim Investigational Site
San Antonio, Texas, United States
1160.129.32288 Boehringer Ingelheim Investigational Site
Sealy, Texas, United States
1160.129.32191 Boehringer Ingelheim Investigational Site
Seguin, Texas, United States
1160.129.32068 Boehringer Ingelheim Investigational Site
Sugar Land, Texas, United States
1160.129.32306 Boehringer Ingelheim Investigational Site
Tyler, Texas, United States
1160.129.32345 Boehringer Ingelheim Investigational Site
Tyler, Texas, United States
1160.129.32418 Boehringer Ingelheim Investigational Site
Tyler, Texas, United States
1160.129.32334 Boehringer Ingelheim Investigational Site
Waco, Texas, United States
1160.129.32175 Boehringer Ingelheim Investigational Site
Whitney, Texas, United States
United States, Utah
1160.129.32034 Boehringer Ingelheim Investigational Site
Salt Lake City, Utah, United States
1160.129.32121 Boehringer Ingelheim Investigational Site
Salt Lake City, Utah, United States
United States, Virginia
1160.129.32166 Boehringer Ingelheim Investigational Site
Burke, Virginia, United States
1160.129.32377 Boehringer Ingelheim Investigational Site
Charlottesville, Virginia, United States
1160.129.32004 Boehringer Ingelheim Investigational Site
Chesapeake, Virginia, United States
1160.129.32067 Boehringer Ingelheim Investigational Site
Danville, Virginia, United States
1160.129.32146 Boehringer Ingelheim Investigational Site
Falls Church, Virginia, United States
1160.129.32430 Boehringer Ingelheim Investigational Site
Fredericksburg, Virginia, United States
1160.129.32363 Boehringer Ingelheim Investigational Site
Harrisonburg, Virginia, United States
1160.129.32200 Boehringer Ingelheim Investigational Site
Manassas, Virginia, United States
1160.129.32328 Boehringer Ingelheim Investigational Site
Manassas, Virginia, United States
1160.129.32279 Boehringer Ingelheim Investigational Site
Midlothian, Virginia, United States
1160.129.32403 Boehringer Ingelheim Investigational Site
Richmond, Virginia, United States
1160.129.32357 Boehringer Ingelheim Investigational Site
Roanoke, Virginia, United States
1160.129.32367 Boehringer Ingelheim Investigational Site
Salem, Virginia, United States
1160.129.32369 Boehringer Ingelheim Investigational Site
Winchester, Virginia, United States
United States, Washington
1160.129.32227 Boehringer Ingelheim Investigational Site
Port Orchard, Washington, United States
1160.129.32241 Boehringer Ingelheim Investigational Site
Seattle, Washington, United States
1160.129.32373 Boehringer Ingelheim Investigational Site
Tacoma, Washington, United States
1160.129.32362 Boehringer Ingelheim Investigational Site
Yakima, Washington, United States
United States, West Virginia
1160.129.32385 Boehringer Ingelheim Investigational Site
Charleston, West Virginia, United States
1160.129.32028 Boehringer Ingelheim Investigational Site
Huntington, West Virginia, United States
1160.129.32359 Boehringer Ingelheim Investigational Site
Huntington, West Virginia, United States
United States, Wisconsin
1160.129.32308 Boehringer Ingelheim Investigational Site
La Crosse, Wisconsin, United States
1160.129.32041 Boehringer Ingelheim Investigational Site
Milwaukee, Wisconsin, United States
1160.129.32058 Boehringer Ingelheim Investigational Site
Milwaukee, Wisconsin, United States
1160.129.32088 Boehringer Ingelheim Investigational Site
Milwaukee, Wisconsin, United States
1160.129.32325 Boehringer Ingelheim Investigational Site
Milwaukee, Wisconsin, United States
1160.129.32355 Boehringer Ingelheim Investigational Site
Waukesha, Wisconsin, United States
Argentina
1160.129.21008 Boehringer Ingelheim Investigational Site
Buenos Aires, Argentina
1160.129.21009 Boehringer Ingelheim Investigational Site
Buenos Aires, Argentina
1160.129.21012 Boehringer Ingelheim Investigational Site
Buenos Aires, Argentina
1160.129.21017 Boehringer Ingelheim Investigational Site
Buenos Aires, Argentina
1160.129.21019 Boehringer Ingelheim Investigational Site
Buenos Aires, Argentina
1160.129.21022 Boehringer Ingelheim Investigational Site
Caba, Argentina
1160.129.21020 Boehringer Ingelheim Investigational Site
Cordoba, Argentina
1160.129.21006 Boehringer Ingelheim Investigational Site
Corrientes, Argentina
1160.129.21010 Boehringer Ingelheim Investigational Site
Godoy Cruz, Argentina
1160.129.21026 Boehringer Ingelheim Investigational Site
Mar del Plata, Argentina
1160.129.21018 Boehringer Ingelheim Investigational Site
Mendoza, Argentina
1160.129.21023 Boehringer Ingelheim Investigational Site
Ramos Mejía, Argentina
1160.129.21015 Boehringer Ingelheim Investigational Site
Rosario, Argentina
1160.129.21021 Boehringer Ingelheim Investigational Site
San Isidro, Argentina
1160.129.21025 Boehringer Ingelheim Investigational Site
San Isidro, Argentina
1160.129.21027 Boehringer Ingelheim Investigational Site
Santa Fe, Argentina
1160.129.21014 Boehringer Ingelheim Investigational Site
Temperley, Argentina
1160.129.21024 Boehringer Ingelheim Investigational Site
Tucuman, Argentina
1160.129.21013 Boehringer Ingelheim Investigational Site
Tucumán, Argentina
1160.129.21028 Boehringer Ingelheim Investigational Site
Villa Luro, Argentina
Brazil
1160.129.22011 Boehringer Ingelheim Investigational Site
Belo Horizonte, Brazil
1160.129.22046 Boehringer Ingelheim Investigational Site
Belo Horizonte, Brazil
1160.129.22029 Boehringer Ingelheim Investigational Site
Blumenau, Brazil
1160.129.22004 Boehringer Ingelheim Investigational Site
Brasilia, Brazil
1160.129.22022 Boehringer Ingelheim Investigational Site
Brasilia, Brazil
1160.129.22047 Boehringer Ingelheim Investigational Site
Campina Grande do Sul, Brazil
1160.129.22017 Boehringer Ingelheim Investigational Site
Campinas, Brazil
1160.129.22041 Boehringer Ingelheim Investigational Site
Campinas, Brazil
1160.129.22039 Boehringer Ingelheim Investigational Site
Caxias do Sul, Brazil
1160.129.22016 Boehringer Ingelheim Investigational Site
Curitiba, Brazil
1160.129.22049 Boehringer Ingelheim Investigational Site
Goiania, Brazil
1160.129.22024 Boehringer Ingelheim Investigational Site
Maceio, Brazil
1160.129.22021 Boehringer Ingelheim Investigational Site
Passo Fundo, Brazil
1160.129.22005 Boehringer Ingelheim Investigational Site
Porto Alegre, Brazil
1160.129.22026 Boehringer Ingelheim Investigational Site
Porto Alegre, Brazil
1160.129.22030 Boehringer Ingelheim Investigational Site
Recife, Brazil
1160.129.22045 Boehringer Ingelheim Investigational Site
Recife, Brazil
1160.129.22033 Boehringer Ingelheim Investigational Site
Rio de Janeiro, Brazil
1160.129.22035 Boehringer Ingelheim Investigational Site
Rio de Janeiro, Brazil
1160.129.22002 Boehringer Ingelheim Investigational Site
Salvador, Brazil
1160.129.22023 Boehringer Ingelheim Investigational Site
Salvador, Brazil
1160.129.22042 Boehringer Ingelheim Investigational Site
Salvador, Brazil
1160.129.22001 Boehringer Ingelheim Investigational Site
Sao Jose do Rio Preto, Brazil
1160.129.22003 Boehringer Ingelheim Investigational Site
Sao Paulo, Brazil
1160.129.22008 Boehringer Ingelheim Investigational Site
Sao Paulo, Brazil
1160.129.22009 Boehringer Ingelheim Investigational Site
Sao Paulo, Brazil
1160.129.22018 Boehringer Ingelheim Investigational Site
Sao Paulo, Brazil
1160.129.22040 Boehringer Ingelheim Investigational Site
Sao Paulo, Brazil
1160.129.22043 Boehringer Ingelheim Investigational Site
São Paulo, Brazil
1160.129.22044 Boehringer Ingelheim Investigational Site
São Paulo, Brazil
1160.129.22048 Boehringer Ingelheim Investigational Site
São Paulo, Brazil
1160.129.22032 Boehringer Ingelheim Investigational Site
Tatui, Brazil
1160.129.22025 Boehringer Ingelheim Investigational Site
Votuporanga, Brazil
Canada, Alberta
1160.129.06018 Boehringer Ingelheim Investigational Site
Calgary, Alberta, Canada
1160.129.06004 Boehringer Ingelheim Investigational Site
Edmonton, Alberta, Canada
Canada, British Columbia
1160.129.06005 Boehringer Ingelheim Investigational Site
Coquitlam, British Columbia, Canada
1160.129.06027 Boehringer Ingelheim Investigational Site
Kelowna, British Columbia, Canada
1160.129.06034 Boehringer Ingelheim Investigational Site
Richmond, British Columbia, Canada
1160.129.06044 Boehringer Ingelheim Investigational Site
Surrey, British Columbia, Canada
1160.129.06021 Boehringer Ingelheim Investigational Site
Victoria, British Columbia, Canada
Canada, New Brunswick
1160.129.06040 Boehringer Ingelheim Investigational Site
Saint John, New Brunswick, Canada
Canada, Newfoundland and Labrador
1160.129.06007 Boehringer Ingelheim Investigational Site
St. John's, Newfoundland and Labrador, Canada
Canada, Nova Scotia
1160.129.06010 Boehringer Ingelheim Investigational Site
Antigonish, Nova Scotia, Canada
1160.129.06025 Boehringer Ingelheim Investigational Site
Halifax, Nova Scotia, Canada
Canada, Ontario
1160.129.06023 Boehringer Ingelheim Investigational Site
Cambridge, Ontario, Canada
1160.129.06020 Boehringer Ingelheim Investigational Site
Grimsby, Ontario, Canada
1160.129.06016 Boehringer Ingelheim Investigational Site
Hamilton, Ontario, Canada
1160.129.06032 Boehringer Ingelheim Investigational Site
Hamilton, Ontario, Canada
1160.129.06043 Boehringer Ingelheim Investigational Site
Hamilton, Ontario, Canada
1160.129.06038 Boehringer Ingelheim Investigational Site
London, Ontario, Canada
1160.129.06028 Boehringer Ingelheim Investigational Site
MIssissauga, Ontario, Canada
1160.129.06037 Boehringer Ingelheim Investigational Site
Newmarket, Ontario, Canada
1160.129.06017 Boehringer Ingelheim Investigational Site
Oakville, Ontario, Canada
1160.129.06001 Boehringer Ingelheim Investigational Site
Oshawa, Ontario, Canada
1160.129.06013 Boehringer Ingelheim Investigational Site
Ottawa, Ontario, Canada
1160.129.06041 Boehringer Ingelheim Investigational Site
Ottawa, Ontario, Canada
1160.129.06042 Boehringer Ingelheim Investigational Site
Stoney Creek, Ontario, Canada
1160.129.06003 Boehringer Ingelheim Investigational Site
Toronto, Ontario, Canada
1160.129.06026 Boehringer Ingelheim Investigational Site
Toronto, Ontario, Canada
1160.129.06029 Boehringer Ingelheim Investigational Site
Toronto, Ontario, Canada
1160.129.06031 Boehringer Ingelheim Investigational Site
Toronto, Ontario, Canada
1160.129.06036 Boehringer Ingelheim Investigational Site
Toronto, Ontario, Canada
Canada, Quebec
1160.129.06024 Boehringer Ingelheim Investigational Site
Chicoutimi, Quebec, Canada
1160.129.06014 Boehringer Ingelheim Investigational Site
Levis, Quebec, Canada
1160.129.06009 Boehringer Ingelheim Investigational Site
Montreal, Quebec, Canada
1160.129.06006 Boehringer Ingelheim Investigational Site
Québec, Quebec, Canada
1160.129.06022 Boehringer Ingelheim Investigational Site
Sainte-Foy, Quebec, Canada
1160.129.06039 Boehringer Ingelheim Investigational Site
Sherbrooke, Quebec, Canada
1160.129.06030 Boehringer Ingelheim Investigational Site
St-Jean-sur-Richel, Quebec, Canada
Canada, Saskatchewan
1160.129.06002 Boehringer Ingelheim Investigational Site
Saskatoon, Saskatchewan, Canada
Chile
1160.129.56001 Boehringer Ingelheim Investigational Site
Las Condes, Chile
1160.129.56006 Boehringer Ingelheim Investigational Site
Santiago, Chile
1160.129.56007 Boehringer Ingelheim Investigational Site
Santiago, Chile
1160.129.56008 Boehringer Ingelheim Investigational Site
Santiago, Chile
1160.129.56010 Boehringer Ingelheim Investigational Site
Santiago, Chile
1160.129.56003 Boehringer Ingelheim Investigational Site
Temuco, Chile
1160.129.56005 Boehringer Ingelheim Investigational Site
Vitacura, Chile
1160.129.56009 Boehringer Ingelheim Investigational Site
Viña del Mar, Chile
China
1160.129.08017 Boehringer Ingelheim Investigational Site
Beijing, China
1160.129.08018 Boehringer Ingelheim Investigational Site
Beijing, China
1160.129.08019 Boehringer Ingelheim Investigational Site
Beijing, China
1160.129.08023 Boehringer Ingelheim Investigational Site
Beijing, China
1160.129.08024 Boehringer Ingelheim Investigational Site
Beijing, China
1160.129.08110 Boehringer Ingelheim Investigational Site
Beijing, China
1160.129.08039 Boehringer Ingelheim Investigational Site
Changchun, China
1160.129.08007 Boehringer Ingelheim Investigational Site
Changsha, China
1160.129.08076 Boehringer Ingelheim Investigational Site
Changsha, China
1160.129.08041 Boehringer Ingelheim Investigational Site
Chengdu, China
1160.129.08049 Boehringer Ingelheim Investigational Site
Chengdu, China
1160.129.08083 Boehringer Ingelheim Investigational Site
Dalian, China
1160.129.08102 Boehringer Ingelheim Investigational Site
Foshan, China
1160.129.08078 Boehringer Ingelheim Investigational Site
Fuzhou, China
1160.129.08001 Boehringer Ingelheim Investigational Site
Guangzhou, China
1160.129.08005 Boehringer Ingelheim Investigational Site
Guangzhou, China
1160.129.08060 Boehringer Ingelheim Investigational Site
Guangzhou, China
1160.129.08103 Boehringer Ingelheim Investigational Site
Guangzhou, China
1160.129.08011 Boehringer Ingelheim Investigational Site
Hangzhou, China
1160.129.08109 Boehringer Ingelheim Investigational Site
Hangzhou, China
1160.129.08047 Boehringer Ingelheim Investigational Site
Jinan, China
1160.129.08050 Boehringer Ingelheim Investigational Site
Jinan, China
1160.129.08114 Boehringer Ingelheim Investigational Site
Jinan, China
1160.129.08120 Boehringer Ingelheim Investigational Site
Jinan, China
1160.129.08122 Boehringer Ingelheim Investigational Site
Jining, China
1160.129.08065 Boehringer Ingelheim Investigational Site
Nanchang, China
1160.129.08026 Boehringer Ingelheim Investigational Site
Nanjing, China
1160.129.08052 Boehringer Ingelheim Investigational Site
QingDao, China
1160.129.08053 Boehringer Ingelheim Investigational Site
Qingdao, China
1160.129.08054 Boehringer Ingelheim Investigational Site
Qingdao, China
1160.129.08092 Boehringer Ingelheim Investigational Site
Qingdao, China
1160.129.08095 Boehringer Ingelheim Investigational Site
Qingdao, China
1160.129.08096 Boehringer Ingelheim Investigational Site
Qingdao, China
1160.129.08098 Boehringer Ingelheim Investigational Site
Qingdao, China
1160.129.08099 Boehringer Ingelheim Investigational Site
Qingdao, China
1160.129.08012 Boehringer Ingelheim Investigational Site
Shanghai, China
1160.129.08014 Boehringer Ingelheim Investigational Site
Shanghai, China
1160.129.08027 Boehringer Ingelheim Investigational Site
Shanghai, China
1160.129.08029 Boehringer Ingelheim Investigational Site
Shanghai, China
1160.129.08031 Boehringer Ingelheim Investigational Site
Shanghai, China
1160.129.08032 Boehringer Ingelheim Investigational Site
Shanghai, China
1160.129.08035 Boehringer Ingelheim Investigational Site
Shanghai, China
1160.129.08036 Boehringer Ingelheim Investigational Site
Shanghai, China
1160.129.08037 Boehringer Ingelheim Investigational Site
Shanghai, China
1160.129.08106 Boehringer Ingelheim Investigational Site
Shanghai, China
1160.129.08080 Boehringer Ingelheim Investigational Site
Shenyang, China
1160.129.08081 Boehringer Ingelheim Investigational Site
Shenyang, China
1160.129.08091 Boehringer Ingelheim Investigational Site
Shenyang, China
1160.129.08105 Boehringer Ingelheim Investigational Site
Shenzhen, China
1160.129.08066 Boehringer Ingelheim Investigational Site
Shijiazhuang, China
1160.129.08107 Boehringer Ingelheim Investigational Site
Shijiazhuang, China
1160.129.08063 Boehringer Ingelheim Investigational Site
Suzhou, China
1160.129.08051 Boehringer Ingelheim Investigational Site
Tai'an, China
1160.129.08116 Boehringer Ingelheim Investigational Site
Taiyuan, China
1160.129.08043 Boehringer Ingelheim Investigational Site
Tianjin, China
1160.129.08075 Boehringer Ingelheim Investigational Site
Wuhan, China
1160.129.08115 Boehringer Ingelheim Investigational Site
Wuhan, China
1160.129.08090 Boehringer Ingelheim Investigational Site
Xi'An, China
1160.129.08077 Boehringer Ingelheim Investigational Site
Xiamen, China
1160.129.08100 Boehringer Ingelheim Investigational Site
Xiamen, China
1160.129.08119 Boehringer Ingelheim Investigational Site
Xuzhou, China
1160.129.08113 Boehringer Ingelheim Investigational Site
Yangzhou, China
1160.129.08111 Boehringer Ingelheim Investigational Site
Zhengzhou, China
1160.129.08112 Boehringer Ingelheim Investigational Site
Zhengzhou, China
1160.129.08121 Boehringer Ingelheim Investigational Site
Zhengzhou, China
1160.129.08117 Boehringer Ingelheim Investigational Site
Zoucheng, China
Colombia
1160.129.24011 Boehringer Ingelheim Investigational Site
Bogota DC, Colombia
1160.129.24003 Boehringer Ingelheim Investigational Site
Bogota, Colombia
1160.129.24006 Boehringer Ingelheim Investigational Site
Bogotá, Colombia
1160.129.24019 Boehringer Ingelheim Investigational Site
Bogotá, Colombia
1160.129.24014 Boehringer Ingelheim Investigational Site
Cali -Valle del Cauca, Colombia
1160.129.24002 Boehringer Ingelheim Investigational Site
Cali, Colombia
1160.129.24007 Boehringer Ingelheim Investigational Site
Cartagena de Indias, Colombia
1160.129.24017 Boehringer Ingelheim Investigational Site
Floridablanca, Colombia
1160.129.24008 Boehringer Ingelheim Investigational Site
Manizales, Colombia
1160.129.24015 Boehringer Ingelheim Investigational Site
Medellin, Colombia
1160.129.24016 Boehringer Ingelheim Investigational Site
Medellin, Colombia
1160.129.24005 Boehringer Ingelheim Investigational Site
Quindio, Colombia
Ecuador
1160.129.25001 Boehringer Ingelheim Investigational Site
Guayaquil, Ecuador
1160.129.25007 Boehringer Ingelheim Investigational Site
Guayaquil, Ecuador
1160.129.25012 Boehringer Ingelheim Investigational Site
Guayaquil, Ecuador
1160.129.25008 Boehringer Ingelheim Investigational Site
Quito, Ecuador
1160.129.25009 Boehringer Ingelheim Investigational Site
Quito, Ecuador
1160.129.25010 Boehringer Ingelheim Investigational Site
Quito, Ecuador
Hong Kong
1160.129.35001 Boehringer Ingelheim Investigational Site
Hong Kong, Hong Kong
1160.129.35002 Boehringer Ingelheim Investigational Site
Hong Kong, Hong Kong
1160.129.35003 Boehringer Ingelheim Investigational Site
Hong Kong, Hong Kong
1160.129.35004 Boehringer Ingelheim Investigational Site
Hong Kong, Hong Kong
Japan
1160.129.60030 Boehringer Ingelheim Investigational Site
Chiba, Asahi, Japan
1160.129.60003 Boehringer Ingelheim Investigational Site
Chiba, Matsudo, Japan
1160.129.60022 Boehringer Ingelheim Investigational Site
Ehime, Matsuyama, Japan
1160.129.60039 Boehringer Ingelheim Investigational Site
Fukui, Fukui, Japan
1160.129.60031 Boehringer Ingelheim Investigational Site
Fukuoka, Fukuoka, Japan
1160.129.60025 Boehringer Ingelheim Investigational Site
Fukuoka, Iizuka, Japan
1160.129.60029 Boehringer Ingelheim Investigational Site
Fukuoka, Itoshima, Japan
1160.129.60026 Boehringer Ingelheim Investigational Site
Fukuoka, Kasuga, Japan
1160.129.60027 Boehringer Ingelheim Investigational Site
Fukuoka, Kitakyushu, Japan
1160.129.60028 Boehringer Ingelheim Investigational Site
Fukuoka, Onga, Japan
1160.129.60001 Boehringer Ingelheim Investigational Site
Hokkaido, Sapporo, Japan
1160.129.60019 Boehringer Ingelheim Investigational Site
Hyogo, Kobe, Japan
1160.129.60018 Boehringer Ingelheim Investigational Site
Hyogo, Takarazuka, Japan
1160.129.60040 Boehringer Ingelheim Investigational Site
Isikawa, Nomi, Japan
1160.129.60021 Boehringer Ingelheim Investigational Site
Kagawa , Higashikagawa, Japan
1160.129.60032 Boehringer Ingelheim Investigational Site
Kagawa , Takamatsu, Japan
1160.129.60007 Boehringer Ingelheim Investigational Site
Kanagawa, Kawasaki, Japan
1160.129.60043 Boehringer Ingelheim Investigational Site
Kanagawa, Kawasaki, Japan
1160.129.60008 Boehringer Ingelheim Investigational Site
Kanagawa, Sagamihara, Japan
1160.129.60023 Boehringer Ingelheim Investigational Site
Kochi, Kochi, Japan
1160.129.60024 Boehringer Ingelheim Investigational Site
Kochi, Kochi, Japan
1160.129.60036 Boehringer Ingelheim Investigational Site
Kumamoto, Kumamoto, Japan
1160.129.60042 Boehringer Ingelheim Investigational Site
Kumamoto, Yatsushiro, Japan
1160.129.60012 Boehringer Ingelheim Investigational Site
Kyoto, Uji, Japan
1160.129.60009 Boehringer Ingelheim Investigational Site
Nagano, Iida, Japan
1160.129.60034 Boehringer Ingelheim Investigational Site
Nagano, Suwa, Japan
1160.129.60037 Boehringer Ingelheim Investigational Site
Niigata, Nagaoka, Japan
1160.129.60015 Boehringer Ingelheim Investigational Site
Osaka, Daito, Japan
1160.129.60017 Boehringer Ingelheim Investigational Site
Osaka, Kawachinagano, Japan
1160.129.60013 Boehringer Ingelheim Investigational Site
Osaka, Matsubara, Japan
1160.129.60014 Boehringer Ingelheim Investigational Site
Osaka, Osaka, Japan
1160.129.60016 Boehringer Ingelheim Investigational Site
Osaka, Osaka, Japan
1160.129.60045 Boehringer Ingelheim Investigational Site
Osaka, Osaka, Japan
1160.129.60041 Boehringer Ingelheim Investigational Site
Osaka, Yao, Japan
1160.129.60044 Boehringer Ingelheim Investigational Site
Saitama, Okegawa, Japan
1160.129.60002 Boehringer Ingelheim Investigational Site
Saitama, Tokorozawa, Japan
1160.129.60011 Boehringer Ingelheim Investigational Site
Shiga, Kusatsu, Japan
1160.129.60010 Boehringer Ingelheim Investigational Site
Shizuoka, Shizuoka, Japan
1160.129.60038 Boehringer Ingelheim Investigational Site
Tokyo, Chuo-ku, Japan
1160.129.60006 Boehringer Ingelheim Investigational Site
Tokyo, Hachioji, Japan
1160.129.60005 Boehringer Ingelheim Investigational Site
Tokyo, Kodaira, Japan
1160.129.60035 Boehringer Ingelheim Investigational Site
Tokyo, Minato-ku, Japan
1160.129.60004 Boehringer Ingelheim Investigational Site
Tokyo, Setagaya, Japan
1160.129.60033 Boehringer Ingelheim Investigational Site
Toyama, Toyama, Japan
Korea, Republic of
1160.129.11026 Boehringer Ingelheim Investigational Site
Bucheon, Korea, Republic of
1160.129.11007 Boehringer Ingelheim Investigational Site
Busan, Korea, Republic of
1160.129.11008 Boehringer Ingelheim Investigational Site
Busan, Korea, Republic of
1160.129.11011 Boehringer Ingelheim Investigational Site
Busan, Korea, Republic of
1160.129.11017 Boehringer Ingelheim Investigational Site
Busan, Korea, Republic of
1160.129.11013 Boehringer Ingelheim Investigational Site
Daegu, Korea, Republic of
1160.129.11014 Boehringer Ingelheim Investigational Site
Daegu, Korea, Republic of
1160.129.11019 Boehringer Ingelheim Investigational Site
Daegu, Korea, Republic of
1160.129.11024 Boehringer Ingelheim Investigational Site
Daegu, Korea, Republic of
1160.129.11003 Boehringer Ingelheim Investigational Site
Daejeon, Korea, Republic of
1160.129.11030 Boehringer Ingelheim Investigational Site
Daejeon, Korea, Republic of
1160.129.11016 Boehringer Ingelheim Investigational Site
Gwangju, Korea, Republic of
1160.129.11006 Boehringer Ingelheim Investigational Site
Iksan, Korea, Republic of
1160.129.11020 Boehringer Ingelheim Investigational Site
Jeju, Korea, Republic of
1160.129.11022 Boehringer Ingelheim Investigational Site
Jeonju, Korea, Republic of
1160.129.11021 Boehringer Ingelheim Investigational Site
Jinju, Korea, Republic of
1160.129.11029 Boehringer Ingelheim Investigational Site
Pusan, Korea, Republic of
1160.129.11010 Boehringer Ingelheim Investigational Site
Seongnam, Korea, Republic of
1160.129.11001 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
1160.129.11002 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
1160.129.11004 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
1160.129.11009 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
1160.129.11012 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
1160.129.11018 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
1160.129.11023 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
1160.129.11025 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
1160.129.11028 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
1160.129.11031 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
1160.129.11005 Boehringer Ingelheim Investigational Site
Suwon, Korea, Republic of
1160.129.11027 Boehringer Ingelheim Investigational Site
Ulsan, Korea, Republic of
1160.129.11015 Boehringer Ingelheim Investigational Site
Yangsan, Korea, Republic of
Lebanon
1160.129.07011 Boehringer Ingelheim Investigational Site
Baabda, Lebanon
1160.129.07004 Boehringer Ingelheim Investigational Site
Beirut, Lebanon
1160.129.07009 Boehringer Ingelheim Investigational Site
Beirut, Lebanon
1160.129.07010 Boehringer Ingelheim Investigational Site
Beirut, Lebanon
1160.129.7002 Boehringer Ingelheim Investigational Site
Beirut, Lebanon
1160.129.7007 Boehringer Ingelheim Investigational Site
Beirut, Lebanon
1160.129.7005 Boehringer Ingelheim Investigational Site
Byblos, Lebanon
1160.129.7006 Boehringer Ingelheim Investigational Site
Saida, Lebanon
Mexico
1160.129.26011 Boehringer Ingelheim Investigational Site
Acapulco de Juárez, Guerrero, Mexico
1160.129.26027 Boehringer Ingelheim Investigational Site
Aguascalientes, Mexico
1160.129.26033 Boehringer Ingelheim Investigational Site
Aguascalientes, Mexico
1160.129.26017 Boehringer Ingelheim Investigational Site
Chihuahua, Mexico
1160.129.26002 Boehringer Ingelheim Investigational Site
Culiacan, Mexico
1160.129.26043 Boehringer Ingelheim Investigational Site
Culiacan, Mexico
1160.129.26008 Boehringer Ingelheim Investigational Site
Distrito Federal, Mexico
1160.129.26004 Boehringer Ingelheim Investigational Site
Durango, Mexico
1160.129.26036 Boehringer Ingelheim Investigational Site
Guadalajara, Mexico
1160.129.26037 Boehringer Ingelheim Investigational Site
Guadalajara, Mexico
1160.129.26038 Boehringer Ingelheim Investigational Site
Guadalajara, Mexico
1160.129.26039 Boehringer Ingelheim Investigational Site
Guadalajara, Mexico
1160.129.26045 Boehringer Ingelheim Investigational Site
Guadalajara, Mexico
1160.129.26046 Boehringer Ingelheim Investigational Site
Guadalajara, Mexico
1160.129.26042 Boehringer Ingelheim Investigational Site
Mexico, Mexico
1160.129.26016 Boehringer Ingelheim Investigational Site
Monterrey, Nuevo Leon, Mexico
1160.129.26005 Boehringer Ingelheim Investigational Site
Monterrey, Mexico
1160.129.26044 Boehringer Ingelheim Investigational Site
Monterrrey, Mexico
1160.129.26029 Boehringer Ingelheim Investigational Site
Morelia, Michoacan, Mexico
1160.129.26012 Boehringer Ingelheim Investigational Site
Mérida, Yucatán, Mexico
1160.129.26047 Boehringer Ingelheim Investigational Site
México, Mexico
1160.129.26040 Boehringer Ingelheim Investigational Site
Orizaba, Mexico
1160.129.26041 Boehringer Ingelheim Investigational Site
Querétaro, Mexico
1160.129.26013 Boehringer Ingelheim Investigational Site
San Luis Potosi, Mexico
1160.129.26015 Boehringer Ingelheim Investigational Site
Tijuana, Mexico
1160.129.26003 Boehringer Ingelheim Investigational Site
Toluca, Estado de Mexico, Mexico
Peru
1160.129.27012 Boehringer Ingelheim Investigational Site
Arequipa, Peru
1160.129.27013 Boehringer Ingelheim Investigational Site
Bellavista, Peru
1160.129.27011 Boehringer Ingelheim Investigational Site
Callao, Peru
1160.129.27001 Boehringer Ingelheim Investigational Site
La Victoria, Peru
1160.129.27009 Boehringer Ingelheim Investigational Site
Lima, Peru
1160.129.27010 Boehringer Ingelheim Investigational Site
Lima, Peru
1160.129.27017 Boehringer Ingelheim Investigational Site
Lima, Peru
1160.129.27019 Boehringer Ingelheim Investigational Site
Lima, Peru
1160.129.27016 Boehringer Ingelheim Investigational Site
Lince, Peru
1160.129.27002 Boehringer Ingelheim Investigational Site
San Borja, Peru
1160.129.27018 Boehringer Ingelheim Investigational Site
San Borja, Peru
1160.129.27007 Boehringer Ingelheim Investigational Site
San Isidro, Peru
1160.129.27003 Boehringer Ingelheim Investigational Site
San Martin de Porres, Peru
Russian Federation
1160.129.33024 Boehringer Ingelheim Investigational Site
Barnaul, Russian Federation
1160.129.33018 Boehringer Ingelheim Investigational Site
Chelyabinsk, Russian Federation
1160.129.33010 Boehringer Ingelheim Investigational Site
Chita, Russian Federation
1160.129.33029 Boehringer Ingelheim Investigational Site
Dzerjinskiy, Russian Federation
1160.129.33027 Boehringer Ingelheim Investigational Site
Ekaterinburg, Russian Federation
1160.129.33016 Boehringer Ingelheim Investigational Site
Irkutsk, Russian Federation
1160.129.33006 Boehringer Ingelheim Investigational Site
Izhevsk, Russian Federation
1160.129.33009 Boehringer Ingelheim Investigational Site
Kemerovo, Russian Federation
1160.129.33026 Boehringer Ingelheim Investigational Site
Krasnodar, Russian Federation
1160.129.33017 Boehringer Ingelheim Investigational Site
Krasnoyarsk, Russian Federation
1160.129.33019 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
1160.129.33020 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
1160.129.33021 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
1160.129.33030 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
1160.129.33002 Boehringer Ingelheim Investigational Site
Novosibirsk, Russian Federation
1160.129.33022 Boehringer Ingelheim Investigational Site
Omsk, Russian Federation
1160.129.33013 Boehringer Ingelheim Investigational Site
Orenburg, Russian Federation
1160.129.33001 Boehringer Ingelheim Investigational Site
Perm, Russian Federation
1160.129.33023 Boehringer Ingelheim Investigational Site
Rostov-on-Don, Russian Federation
1160.129.33028 Boehringer Ingelheim Investigational Site
Ryazan, Russian Federation
1160.129.33015 Boehringer Ingelheim Investigational Site
Samara, Russian Federation
1160.129.33025 Boehringer Ingelheim Investigational Site
Samara, Russian Federation
1160.129.33005 Boehringer Ingelheim Investigational Site
Saratov, Russian Federation
1160.129.33003 Boehringer Ingelheim Investigational Site
St. Petersburg, Russian Federation
1160.129.33004 Boehringer Ingelheim Investigational Site
St. Petersburg, Russian Federation
1160.129.33011 Boehringer Ingelheim Investigational Site
Vladivostok, Russian Federation
Saudi Arabia
1160.129.30009 Boehringer Ingelheim Investigational Site
Dammam, Saudi Arabia
1160.129.30007 Boehringer Ingelheim Investigational Site
Hufuf, Saudi Arabia
1160.129.30001 Boehringer Ingelheim Investigational Site
Jeddah, Saudi Arabia
1160.129.30002 Boehringer Ingelheim Investigational Site
Jeddah, Saudi Arabia
1160.129.30008 Boehringer Ingelheim Investigational Site
Jeddah, Saudi Arabia
1160.129.30005 Boehringer Ingelheim Investigational Site
Riyadh, Saudi Arabia
1160.129.30006 Boehringer Ingelheim Investigational Site
Riyadh, Saudi Arabia
1160.129.30003 Boehringer Ingelheim Investigational Site
Tabuk, Saudi Arabia
1160.129.30004 Boehringer Ingelheim Investigational Site
Taif, Saudi Arabia
Singapore
1160.129.45001 Boehringer Ingelheim Investigational Site
Singapore, Singapore
1160.129.45002 Boehringer Ingelheim Investigational Site
Singapore, Singapore
1160.129.45003 Boehringer Ingelheim Investigational Site
Singapore, Singapore
1160.129.45004 Boehringer Ingelheim Investigational Site
Singapore, Singapore
South Africa
1160.129.48006 Boehringer Ingelheim Investigational Site
Durban, South Africa
1160.129.48007 Boehringer Ingelheim Investigational Site
Johannesburg, South Africa
1160.129.48002 Boehringer Ingelheim Investigational Site
Somerset West, Cape Town, South Africa
1160.129.48010 Boehringer Ingelheim Investigational Site
Tongaat, South Africa
Taiwan
1160.129.46007 Boehringer Ingelheim Investigational Site
Kaohsiung, Taiwan
1160.129.46009 Boehringer Ingelheim Investigational Site
Kaohsiung, Taiwan
1160.129.46010 Boehringer Ingelheim Investigational Site
Taichung, Taiwan
1160.129.46008 Boehringer Ingelheim Investigational Site
Tainan, Taiwan
1160.129.46001 Boehringer Ingelheim Investigational Site
Taipei, Taiwan
1160.129.46002 Boehringer Ingelheim Investigational Site
Taipei, Taiwan
1160.129.46004 Boehringer Ingelheim Investigational Site
Taipei, Taiwan
1160.129.46005 Boehringer Ingelheim Investigational Site
Taipei, Taiwan
1160.129.46006 Boehringer Ingelheim Investigational Site
Taipei, Taiwan
1160.129.46003 Boehringer Ingelheim Investigational Site
Taoyuan, Taiwan
United Arab Emirates
1160.129.31003 Boehringer Ingelheim Investigational Site
Abu Dhabi, United Arab Emirates
1160.129.31004 Boehringer Ingelheim Investigational Site
Abu Dhabi, United Arab Emirates
1160.129.31005 Boehringer Ingelheim Investigational Site
Abu Dhabi, United Arab Emirates
1160.129.31006 Boehringer Ingelheim Investigational Site
Abu Dhabi, United Arab Emirates
1160.129.31001 Boehringer Ingelheim Investigational Site
Dubai, United Arab Emirates
1160.129.31002 Boehringer Ingelheim Investigational Site
Sharjah, United Arab Emirates
Venezuela
1160.129.05002 Boehringer Ingelheim Investigational Site
San Roman Caracas, Venezuela
Sponsors and Collaborators
Boehringer Ingelheim
Investigators
Study Chair: Boehringer Ingelheim Boehringer Ingelheim
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Boehringer Ingelheim
ClinicalTrials.gov Identifier: NCT01468701     History of Changes
Other Study ID Numbers: 1160.129
Study First Received: October 28, 2011
Last Updated: August 25, 2017

Additional relevant MeSH terms:
Atrial Fibrillation
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on September 25, 2017